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Background: Traditional Indian and Australian medicinal plant extracts were investigated to determine their
therapeutic potential to inhibit key enzymes in carbohydrate metabolism, which has relevance to the management
of hyperglycemia and type 2 diabetes. The antioxidant activities were also assessed.
Methods: The evaluation of enzyme inhibitory activity of seven Australian aboriginal medicinal plants and five
Indian Ayurvedic plants was carried out against α-amylase and α-glucosidase. Antioxidant activity was determined
by measuring (i) the scavenging effect of plant extracts against 2, 2-diphenyl-1-picryl hydrazyl (DPPH) and 2, 2′-
azinobis-3-ethylbenzothiazoline-6-sulfonate (ABTS) and (ii) ferric reducing power. Total phenolic and total flavonoid
contents were also determined.
Results: Of the twelve plant extracts evaluated, the highest inhibitory activity against both α-amylase and α-
glucosidase enzymes was exerted by Santalum spicatum and Pterocarpus marsupium with IC50 values of 5.43 μg/ml
and 0.9 μg/ml, respectively, and 5.16 μg/ml and 1.06 μg/ml, respectively. However, the extracts of Acacia ligulata
(IC50 = 1.01 μg/ml), Beyeria leshnaultii (0.39 μg/ml), Mucuna pruriens (0.8 μg/ml) and Boerhaavia diffusa (1.72 μg/ml)
exhibited considerable activity against α-glucosidase enzyme only. The free radical scavenging activity was found to
be prominent in extracts of Acacia kempeana, Acacia ligulata followed by Euphorbia drummondii against both DPPH
and ABTS. The reducing power was more pronounced in Euphorbia drummondii and Pterocarpus marsupium
extracts. The phenolic and flavonoid contents ranged from 0.42 to 30.27 μg/mg equivalent of gallic acid and 0.51
to 32.94 μg/mg equivalent of quercetin, respectively, in all plant extracts. Pearson’s correlation coefficient between
total flavonoids and total phenolics was 0.796.
Conclusion: The results obtained in this study showed that most of the plant extracts have good potential for the
management of hyperglycemia, diabetes and the related condition of oxidative stress.
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Diabetes mellitus is an important metabolic syndrome.
The increasing worldwide incidence of diabetes mellitus
in adults constitutes a global public health burden. The
World Health Organization (WHO) estimates that cur-
rently more than 180 million people worldwide have dia-
betes and it is likely to double by 2030, with India,
China and United States predicted to have the largest* Correspondence: epalombo@swin.edu.au
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reproduction in any medium, provided the ornumber of affected individuals [1,2]. Many plants and
their active chemical compounds have demonstrated ac-
tivity in the treatment of various disorders [3]. Accord-
ing to ethnobotanical information, more than 800 plants
are used as traditional remedies in one or other form for
the treatment of diabetes [4]. The management of dia-
betes without any side effects is still a challenge; there-
fore plants continue to play an important role in the
discovery of new compounds for the treatment of this
disease.
The management of diabetes can be achieved by redu-
cing post-prandial hyperglycemia by delaying thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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which are responsible for the digestion of carbohydrates
and absorption of glucose in the digestive tract, respect-
ively [5,6]. Drugs derived from natural products have
played a major role in the development of pharmaceut-
ical treatments for diabetes. Metformin, the single most
prescribed agent for the treatment of diabetes, originated
from herbal medicine [7,8]. A plant-derived antidiabetic
agent, galegine, was isolated from Galega officinalis. Ex-
perimental and clinical evaluations provided the
pharmacological and chemical basis for the subsequent
discovery of metformin [7,9]. 1- deoxynojirimycin (DNJ),
a potent α-glucosidase Inhibitor, was isolated from the
water extract of leaves of the mulberry tree (Morus alba
L.) [10].
There are many cellular biochemical pathways and en-
vironmental toxins which produce reactive oxygen spe-
cies (ROS) [11] and contribute to the development of
diseases such as cancer, cardiovascular disorders, dia-
betes, cataracts and many neurodegenerative diseases
[12]. Many studies have confirmed that plants and foods
rich in polyphenolic content are effective scavengers of
free radicals, thus helping in the prevention of these dis-
eases through their antioxidant activity [13]. Antioxi-
dants which are present in plants, herbs and dietary
sources help in preventing vascular diseases in diabetic
patients [14]. Tannins and flavonoids are the secondary
metabolites in plants considered to be the natural source
of antioxidants which prevent destruction of β-cells and
diabetes-induced ROS formation [15]. Thus, it is a good
strategy to manage diabetes as a whole with plants
which show good enzyme inhibitory and antioxidant ac-
tivities [16]. Therefore, the aim of our study was to
screen some traditional Australian aboriginal plants and
Ayurvedic Indian plant extracts to determine thoseTable 1 Traditional uses of Australian aboriginal and Indian A
Plant Family
Acacia kempeana F. Muell. Mimosaceae Chest infection, se
Acacia. tetragonophylla F. Muell. Mimosaceae Cough, treatment
Acacia ligulata Cunn. ex Benth. Mimosaceae Cough, cold, chest
Beyeria lechenaultii (DC.) Baillon Euphorbiaceae General sickness, f
Euphorbia drummondii Boiss. Euphorbiaceae Skin sores, genital
Santalum lanceolatum R. Br. Santalaceae Cold, malaise, sore
Santalum spicatum (R. Br.) A. DC. Santalaceae Cough
Boerhaavia diffusa Linn. Nyctaginaceae Diuretic, anti-inflam
antihepatotoxic, an
Curculigo orchioides Gaertn. Amaryllidaceae Demulscent, diure
Eugenia jambolana Lam. Myrtaceae Bronchitis, asthma
Mucuna Pruriens Linn. Leguminoseae Anti-parkinson, hyp
antimicrobial




The Australian aboriginal plants were selected on the
basis of availability and their known medicinal activities.
The Indian Ayurvedic plants were selected according to
their reported anti-diabetic potential. These plants were
known to possess anti-diabetic action and but not all
plants had been screened using enzymatic inhibition
assays used in this study. Seven Australian aboriginal
medicinal plant extracts were obtained from the Univer-
sity of South Australia, Adelaide, Australia. Powdered
extracts of five Indian Ayurvedic plants were provided
by Promed Research Centre, Gurgaon, India. Table 1
shows the ethnobotanical uses of the plants used in this
study. Many of the plants screened here have been used
as food or food supplements, suggesting that they are
safe to take orally. Seeds and gums of Acacia species are
edible and, as this plant grows in harsh environments, it
is commonly known as “dead finish”, Santalum lanceo-
latum (SL) has sweet fruits which are eaten fresh and
the decoction of the inner bark of S. spicatum (SS) was
drunk to get relief from coughs [17]. Fruits of Eugenia
jambolana (EJ), called blackberries in English, are eaten
fresh, are rich in polyphenols, are widely distributed in
India and are known to reduce glucose [18]. Seeds of
Mucuna pruriens (MP), also known as velvet beans, are
cooked or can be eaten raw [19] and in Central America
the roasted and ground seeds are used as a substitute for
coffee [20]. Tuberous roots of Curculigo orchioides (CO)
are eaten to maintain vitality, strength and have aphro-
disiac effects [21]. Tribal people of West Bengal eat
Boerrhaavia diffusa (BD) as a vegetable, while in theyurvedic plants used in this study
Use References
vere cold, general sickness [23,24]
of circumcision wounds, dysentery [25]
infection, general illness [24,26,27]
ever [26]
sores, fever, dysentery [23]
throat, venereal diseases, painful urination [23]
[26]
matory, antifibrinolytic, anticonvulsant, antibacterial,
tidiabetic
[22,28]
tic, aphrodisiac, asthma, jaundice, hepatoprotective [21,29]
, sore throat, diabetes, dysentery, antibacterial, antioxidant [18,30,31]
oglycemic, hypo-cholestrolemic, antioxidant, antitumour, [32,33]
taract, cardiotonic, hepatoprotective [32,34]
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[22].
Preparation of extracts
The preparation of Australian aboriginal plants extracts
and information about voucher specimens have previ-
ously been described [23]. The Indian Ayurvedic plants
were provided as dried powders by Promed Research
Centre, India, with the following batch codes: PROM/
PTMA-01 (PM), PROM/BD-43 (BD), PROM/CUOR-15
(CO), PROM/EUJA-10 (EJ) and PROM/MUPR-05 (MP).
Five grams of powder were soaked overnight in 50 ml
ethanol and filtered with Whatmann filter paper No. 1.
The filtrates were concentrated in vacuo in a rotary
evaporator at 55°C and reconstituted in ethanol at
250 μg/μl as a stock solution which was used to make
working solutions of various concentrations. Enzymes
and chemicals (α-amylase enzyme from porcine pan-
creas, yeast α-glucosidase, acarbose, p-nitro phenyl glu-
copyranoside (p-NPG) and 1,1-diphenyl-2-picrylhydrazyl
radical (DPPH), 2,2′-azinobis-3-ethylbenzothiazoline-6-
sulfonate (ABTS), butylated hydroxyl toluene (BHT), po-
tassium ferricyanide, trichloroacetic acid, ascorbic acid,
ferric chloride, Folin-Ciocalteu reagent, quercetin, gallic
acid and aluminium chloride were purchased from
Sigma-Aldrich, Australia.
Amylase inhibition screening assay
The α-amylase inhibitory assay was modified from
Correia et al. [35]. Twenty μl of porcine pancreatic α-
amylase solution (EC 3.2.1.1; equivalent to 3000 U in
50 mM phosphate buffer, pH 6.9) were mixed with
15 μl of plant extract and incubated at 37°C for
45 minutes. After incubation, the plant - enzyme mix-
ture was applied to a sterile paper disc and placed
onto the center of petri plates containing medium
consisting of 1% (w/v) agar and 1% (w/v) starch in dis-
tilled water. Plates were allowed to stand for 3 days at
25°C then stained with iodine and allowed to stand for
15 min. The diameter of the clear zone was
measured and used to calculate the amylase inhibitory
activity. As a control, the enzyme was mixed with
the solvent in which the plants were extracted (etha-
nol) and applied onto the sterile disc. Results
were expressed as percentage (%) amylase inhibition =
{(diameter of control – diameter of sample)/diameter
of the control} × 100.
Amylase inhibition assay by quantitative starch hydrolysis
The α-amylase inhibitory activity was determined [36]
using porcine pancreatic α-amylase solution (EC 3.2.1.1)
type VI B. To 125 μl of different plant extract concentra-
tions (range 1.56 μg/ml to 500 μg/ml), α-amylase solution
(0.5 mg/ml in 0.02 M sodium phosphate buffer) wasmixed and the reaction mixture was pre-incubated for
10 minutes at room temperature. After pre-incubation,
25 μl of 1% (w/v) starch solution were added every 5 sec-
onds for a total of 125 μl. The reaction mixture was again
incubated for 10 minutes at room temperature. The reac-
tion was terminated by adding 250 μl of 3, 5-dinitro sali-
cylic acid reagent. The tubes were placed in boiling water
bath for 5 minutes and then cooled at room temperature.
The reaction mixture was diluted by adding 5000 μl of
distilled water. The generation of maltose was quantified
by measuring the absorbance at 540 nm of 3-amino-5-
nitrosalicylic acid (from reduction of 3, 5-dinitrosalicylic
acid [37]) using a UV-visible spectrophotometer. The
control was buffer treated in the same way as plant sam-
ples. The standard used was acarbose (concentration
range 1.56 μg/ml to 500 μg/ml). Results were expressed as
percentage (%) amylase inhibition = {(absorbance of con-
trol540nm – absorbanceof samples540nm)/absorbance of
the control540nm} × 100.
Glucosidase inhibition assay
The α-glucosidase inhibition assay was modified from
Apostolidis et al. [38] using yeast α-glucosidase (EC –
2328898). A volume of 25 μl of plant extract (range
0.35 μg/ml to 100 μg/ml) was mixed with 50 μl of α-
glucosidase enzyme (0.1 U/ml in 0.1 M potassium phos-
phate buffer solution, pH 6.9) in 96 well plates and incu-
bated at 37°C for 30 minutes. After pre-incubation, 25 μl
of 5 mM pNPG in 0.1 M phosphate buffer were added
to each well and the reaction mixture was incubated
again at 37°C for 30 minutes. Thirty μl of 0.1 M sodium
carbonate solution were added to the above reaction
mixture and incubated again for 20 minutes at 37°C. Be-
fore and after incubation, the absorbance was measured
at 405 nm and compared to the control that contained
25 μl of buffer solution instead of plant extract. The
standard used was acarbose (concentration range
0.35 μg/ml to 100 μg/ml). The α-glucosidase activity was
determined by measuring release of p-nitrophenol from
p-nitrophenyl α-D-glucopyranoside [39]. The α-




=absorbanceof thecontrol 405nmg  100
Total phenolic content assay
The total phenolic content was quantified using a modi-
fied version of the assay described by Singleton et al.
[40] using Folin-Ciocalteu reagent. Twenty μl of plant
sample or gallic acid (standard phenolic compound)
were diluted with 1580 μl of distilled water and then
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mixture was shaken and kept for 6 minutes, after which
300 μl of 5% aqueous Na2CO3 solution were added and
mixed properly. The mixture was incubated for 2 hours
at 20°C. The absorbance was measured for all the sam-
ples at 765 nm. A standard curve was prepared using
25–1000 mg/l of gallic acid. The total phenolic values
were expressed in terms of gallic acid equivalents (μg/
mg of dry mass). The blank (distilled water) was treated
in the same way as the samples and the dilution factor
was taken into account for the samples where dilution
was performed.
Determination of total flavonoids
The total flavonoids were determined using a modifica-
tion of the assay described by Dixit et al. [41]. Plant sam-
ples (250 μl) were diluted with 1250 μl of distilled water
and 75 μl of 5% NaNO2 were added to the sample to-
gether with 150 μl of 10% aluminum chloride. After
mixing and incubation for 5 minutes, 500 μl of 1 M
NaOH were added to the reaction mixture and a total
volume of 2500 μl was made up with distilled water. Fol-
lowing vigorous mixing, the absorbance was measured
at 510 nm. A standard curve was prepared using 25–
1000 mg/l of quercetin. Results were expressed as μg of
quercetin equivalents per milligram of dry mass of the
plant extract.
Antioxidant activity determined by 1, 1-diphenyl-2-
picrylhydrazyl (DPPH) radical inhibition
The DPPH scavenging activity was determined by an
assay modified from Kwon et al. [42]. To 150 μl of
0.1 mM DPPH in methanol, a volume of 50 μl of
plant extract (range 20 to 1000 μg/ml) was mixed and
kept in the dark at room temperature for 60 minutes.
After incubation, the absorbance was recorded at
490 nm. The results were compared with the control
which contained 50 μl of ethanol instead of plant
extracts. The positive controls were butyl hydroxyl
toluene (BHT) and ascorbic acid in concentration
range 3.12 to 250 μg/ml. The antioxidant activity was
expressed aspercentage (%) inhibition = {(absorbance of
control490nm – absorbance of samples490nm)/ absorbance of
the control490nm} × 100.
Antioxidant activity determined by 2,2′-azinobis-3-
ethylbenzothiazoline-6-sulfonate (ABTS) radical inhibition
The free radical scavenging activity of plant extracts was also
studied using the ABTS radical cation. The decolorization
assay is based on reduction of the ABTS+ · radical by plant
extracts having antioxidant capacity [43]. ABTS radical was
dissolved in deionized water to make a 7 mM solution and
2.45 mM potassium persulfate solution was added to the
same. To produce the ABTS free radical cation, the mixturewas allowed to stand in dark at room temperature for 12 to
16 hours. The free radical solution of ABTS was diluted
with ethanol to an absorbance of 0.7 at 734 nm for the assay.
To 990 μl of ABTS free radical solution, a volume of 10 μl
of plant extract (range 1 to 1000 μg/ml) was mixed and kept
in the dark at room temperature for 60 minutes. After incu-
bation, the absorbance was recorded at 734 nm. The results
were compared with the control which contained 10 μl of
ethanol instead of plant extracts. The positive controls
were BHT and ascorbic acid in concentration range
1.56 to 250 μg/ml. The antioxidant activity was expressed as
percentage (%) inhibition = {(absorbance of control734nm –
absorbance of samples734nm)/ absorbance of the con-
trol734nm} × 100.
Ferric reducing power assay
The ferric reducing power assay was carried out as
described by Fawole et al. [44] using 30 μl plant extracts
and standards (BHT and ascorbic acid) of different con-
centrations (range 25 to 1000 μg/ml) added to 96 well
plates along with 40 μl of 0.2 M potassium phosphate
buffer (pH 7.2) and 40 μl of potassium ferricyanide
(1%w/v). The reaction mixtures were incubated at 50°C
for 20 minutes. After incubation, 40 μl of trichloroacetic
acid (10%w/v), 150 μl distilled water and 30 μl of ferric
chloride (0.1%w/v) were added and the reaction mixture
again incubated for 30 minutes at room temperature in
the dark. Absorbance was recorded at 630 nm using a
microplate reader and the positive controls were BHT
and ascorbic acid whereas the negative control was buf-
fer. The absorbance of each sample was plotted against
concentration and compared with the standards.
Statistical analysis
All samples were analyzed in triplicate. Data are pre-
sented as mean± standard error mean (SEM). Differ-
ences were evaluated by one-way analysis of variance
(ANOVA) test completed by a Bonferroni’s multicom-
parison test. Differences were considered significant at
p < 0.01. The concentration giving 50% inhibition
(IC50) was calculated by non-linear regression with the
use of Graphpad Prism Version 5.0 for Windows
(GraphPad Software, San Diego, CA, USA) (www.
graphpad.com). The dose–response curve was obtained
by plotting the percentage inhibition versus concentra-
tion [37].
Results and discussion
The inhibition of digestive enzymes, such as α-amylase
and α-glucosidase, has been considered to be an effective
strategy to control blood glucose. Agents based on nat-
ural products are particularly attractive as side effects are
minimal and the therapies are well-tolerated compared
to the other oral hypoglycemic agents currently available
Figure 1 α-amylase inhibition of selected plants. α-amylase IC50
of ethanolic extracts of (A) Australian aboriginal plants and (B)
Indian Ayurvedic plants. Each value represents the mean± SEM of
triplicates experiments.
Gulati et al. BMC Complementary and Alternative Medicine 2012, 12:77 Page 5 of 9
http://www.biomedcentral.com/1472-6882/12/77[5,36]. The present study was therefore designed to in-
vestigate the bioactive properties of twelve traditional
medicinal plants relevant to the management of hyper-
glycemia and type 2 diabetes. These properties included
inhibition of α-amylase and α-glucosidase enzymes and
antioxidant potential. The total phenolic and total flavon-
oid contents of the extracts were also determined.
Type 2 diabetes is a global health challenge and the
WHO has recommended research and use of comple-
mentary medicines for the management of this disease.
Type 2 diabetes was previously considered as maturity-
onset diabetes but, due to increasing rates of obesity,
there is an increasing risk of developing this disease in
childhood [45,46]. The goal of treatment is to maintain
normal levels of blood glucose and prevent the develop-
ment of skin infections, diabetic nephropathy and car-
diovascular disorders [47].
The results of preliminary agar diffusion amylase
inhibition assays indicated that all of the Australian abo-
riginal plant extracts showed complete inhibition of α-
amylase enzyme such that no hydrolysis of starch was
evident. Among the Indian Ayurvedic plant extracts,
only Eugenia jambolana and Curculigo orchioides
showed complete inhibition at 250 mg/ml. Mucuna
pruriens, Boerhaavia diffusa and Pterocarpus marsu-
pium extracts showed partial inhibition. While the ma-
jority of the extracts demonstrated potent α-amylase
inhibiting activity, some of the Australian plant extracts
were particularly active (Acacia ligulata and Acacia tet-
ragonophylla) and showed activity at concentrations
lower than those of the other extracts.
In the amylase assay (Figure 1A), the positive control
acarbose showed an IC50 of 7.81 μg/ml and the Austra-
lian plant extracts which exerted higher amylase inhibi-
tory activity were SS (5.53 μg/ml), AL, BL and SL. We
did not observe similar activity with extracts of Acacia
tetragonophylla (AT), Euphorbia drumondii (ED) and
Acacia kempeana (AK) which showed IC50 values in the
range 32 to 66 μg/ml. The same plant extracts showed
statistically significant low IC50 (in the range 0.48 to
1.83 μg/ml) as compared to acarbose (4.41 μg/ml) for
glucosidase inhibition (Figure 2A).
For amylase inhibition, among the five Indian plant
extracts screened, only PM extract showed a lower, but
not statistically significant, IC50 of 5.16 μg/ml compared
to acarbose (Figure 1B). EJ, CO and MP extracts showed
IC50 in the range 12.01 to 42.81 μg/ml. Only MP and
PM extracts showed statistically significant lower IC50
value for glucosidase inhibition as compared to acarbose
(Figure 2B).
DPPH is a radical, purple in colour, which is reduced
to the yellow coloured diphenylpicrylhydrazine by plant
extracts. This antioxidant assay is based on the reduc-
tion of alcoholic DPPH solution in the presence ofhydrogen-donating antioxidant due to the formation of
the non-radical form, DPPH-H [48].
The positive controls, ascorbic acid and BHT, were
used for DPPH, ABTS and ferric reducing power assays.
IC50 values (Figure 3A and 3B) were calculated for all
the extracts and controls and were found to be 12.37
and 41.82 μg/ml for ascorbic acid and BHT, respect-
ively. Among the Australian plant extracts, AL showed
nearly half the IC50 value of 6.98 μg/ml whereas the rest
of the plant extracts exerted similar IC50 to that of as-
corbic acid with AT having a five-fold higher IC50 value.
The Indian plant extracts exerted IC50 in range 97 to
883 μg/ml.
ABTS is a stable free radical, bluish-green in colour
and the antioxidant assay is based on the reduction of
Figure 2 α-glucosidase inhibition of selected plants. α-
glucosidase IC50 of ethanolic extracts of (A) Australian aboriginal
plants and (B) Indian Ayurvedic plants. Each value represents the
mean± SEM of triplicates experiments. **** p < 0.001 and *** p < 0.01
indicate a significant difference between acarbose and plant
extracts, one-way ANOVA post-hoc Bonferroni's multiple comparison
test.
Figure 3 DPPH radical scavenging activity of selected plants.
DPPH radical scavenging IC50 of ethanolic extracts of (A) Australian
aboriginal plants and (B) Indian Ayurvedic plants. Each value
represents the mean± SEM of triplicates experiments.
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and 4B) for positive controls, ascorbic acid and BHT,
were found to be 30.20 and 88.24 μg/ml, respectively.
Out of seven Australian plant extracts screened for ABTS
radical scavenging activity, AK showed significantly lower
IC50 as compared to BHT. Barring SL and AT, the rest of
the plant extracts tested showed IC50 value equal or less
than the positive controls tested. The five Indian plant
extracts tested failed to show any significant activity as
compared to positive controls and the IC50 value was in
the range from 195.96 to 374.70 μg/ml.
Antioxidant activities of these plant extracts were
assessed through their ability to reduce the Fe3+/ferricyanide complex to the ferrous (Fe2+) form. The
ferrous ion was monitored by measuring the formation
of Perl’s Prussian blue at 630 nm [49]. Figure 5 presents
the dose-dependent ferric-reducing powers of the sam-
ple extracts, ascorbic acid and BHT. The reducing power
of ED extract showed similar activity to BHT but higher
than ascorbic acid. Among the Indian plant extracts, PM
showed good potential whereas BD and CO showed
moderate activity. Overall, it was seen that most of the
extracts possessed promising antioxidant activity.
Gallic acid and hydroxycinnamic acids are the phen-
olic acids found commonly in plants. Plants which con-
tain high levels of phenolics are considered a good
source of antioxidants and therefore it is important to
Figure 4 ABTS radical scavenging activity of selected plants.
ABTS radical scavenging IC50 of ethanolic extracts of (A) Australian
aboriginal plants and (B) Indian Ayurvedic plants. Each value
represents the mean± SEM of triplicates experiments. **** p < 0.001
indicates significant difference between BHT and plant extract, one-
way ANOVA post-hoc Bonferroni's multiple comparison test.
Figure 5 Ferric ion reducing power activity of selected plants.
Ferric ion-reducing power of extracts of (A) Australian aboriginal
plants and (B) Indian Ayurvedic plants ethanolic extracts, showing a
dose-dependent linear increase in absorbance. Each value represents
the mean± SEM of triplicates experiments.
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extracts as they might have some beneficial effects on
health [50]. The colorimetric assays used here are based
on the chemical reduction of a reagent. For the extracts
tested in this study, total phenolic content ranged from
0.42 - 30.27 μg/mg gallic acid and total flavonoids ran-
ged from 0.51 - 32.94 μg/mg quercetin equivalents
(Table 2). Pearson’s correlation coefficient between total
flavonoids and total phenolic was 0.796.
Although there are scientific reports about anti-
diabetic activities of many Indian plants, there are no
such studies on the activity of Australian plants with re-
spect to diabetes. The Australian medicinal plantsinvestigated in this study (SS, AL, ED, BL, AK, AT and
SL) have been used for general illness, cold, cough and
pain [23]. However, this is the first study to assess the
potential of Australian traditional medicinal plants to be
used in the management of hyperglycemia and diabetes.
The traditional hunter-gatherer lifestyle and diet of Abo-
riginal people, which was high in carbohydrates, fibre,
proteins and nutrients but low in fat and sugars, meant
that cardiovascular diseases and diabetes were not com-
mon in these people. After the settlement of Europeans,
the diet became Westernized with high sugar and fat
content and the lack of essential nutrients, vitamins,
minerals, proteins and fibre. This has increased the dis-
ease risk and these disorders are now prevalent in indi-
genous populations with the incidence of type 2 diabetes
rapidly increasing [51,52].
Flavonoids, alkaloids and triterpenoids may be related
to the anti-diabetic activity of plants. In particular, flavo-
noids are responsible for variety of pharmacological ac-
tivities. For example, epicatechin is known to possess
Table 2 Total phenolic and flavonoid contents for
Australian aboriginal and Indian Ayurvedic plant extracts




Santalum spicatum 0.87 ± 0.11 1.37 ± 0.11
Acacia ligulata 0.95 ± 0.06 1.52 ± 0.36
Euphorbia
drummondii
0.93 ± 0.01 0.51 ± 0.12
Beyeria leshnaultii 0.42 ± 0.038 1.34 ± 0.21
Acacia kempeana 1.47 ± 0.075 1.78 ± 0.15
Acacia
tetragonophylla
0.56 ± 0.17 0.94 ± 0.13
Santalum
lanceolatum
1.28 ± 0.035 1.35 ± 0.18
Eugenia jambolana 28.31 ± 0.22 10.72 ± 0.44
Curculigo orchoides 15.17 ± 0.42 22.18 ± 0.43
Pterocarpus
marsupium
30.27 ± 0.88 32.94 ± 3.24
Boerhaavia diffusa 5.54 ± 0.24 3.58 ± 0.61
Mucuna pruriens 5.83 ± 0.57 13.25 ± 3.7
TPC – total phenolic content, TFC – total flavonoid content.
GAE- gallic acid equivalent, QE- quercetin equivalent.
The results are average of triplicate analysis (n = 3; data expressed as
mean ± SD).
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considered a promising hypoglycemic agent [53]. As
shown in previous studies, the enzyme inhibition activity
may be related to the polyphenolic content of the plant
extract, however further studies are needed to confirm
this.Conclusions
The present study showed the anti-diabetic potential of
a number of medicinal plant extracts. Most of the plants
showed promise as agents for the management of hyper-
glycemia, along with good antioxidant activity. Indeed,
the antioxidant and α-amylase and α-glucosidase inhibi-
tory activities of plants and foods have been associated
with their anti-diabetic activity [42,54,55]. Indian Ayur-
vedic plants have been previously reported to have anti-
diabetic properties; however limited data were available
about the mechanism of action. Therefore, the plants
should be further investigated as they may provide leads
for the discovery of new drugs for the management of
diabetes with minimal side effects.
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